about
Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cellsRegulation of the embryonic morphogen Nodal by Notch4 facilitates manifestation of the aggressive melanoma phenotypeEpithelial-to-Mesenchymal Transition in the Female Reproductive Tract: From Normal Functioning to Disease Pathology.In situ loading of basic fibroblast growth factor within porous silica nanoparticles for a prolonged releaseGPR54 (KISS1R) transactivates EGFR to promote breast cancer cell invasiveness.Matrigel: a complex protein mixture required for optimal growth of cell culture.Microenvironmental regulation of telomerase isoforms in human embryonic stem cellsOxygen as a regulator of cellular phenotypes in pregnancy and cancer.Targeting Nodal in malignant melanoma cells.Low oxygen levels induce the expression of the embryonic morphogen Nodal.Assessing breast cancer cell lines as tumour models by comparison of mRNA expression profiles.A Digital PCR-Based Method for Efficient and Highly Specific Screening of Genome Edited Cells.Nitric oxide signalling and cellular adaptations to changes in oxygenation.Embryonic morphogen nodal promotes breast cancer growth and progression.Post-transcriptional regulation in cancer progression : Microenvironmental control of alternative splicing and translation.Mass spectrometry-based proteomic analysis of the matrix microenvironment in pluripotent stem cell culture.Influence of the microenvironment on melanoma cell fate determination and phenotype.The commonality of plasticity underlying multipotent tumor cells and embryonic stem cells.Illuminating luminal B: QSOX1 as a subtype-specific biomarkerRASSF1A Site-Specific Methylation Hotspots in Cancer and Correlation with RASSF1C and MOAP-1.Nodal signalling in embryogenesis and tumourigenesis.Delivering Antisense Morpholino Oligonucleotides to Target Telomerase Splice Variants in Human Embryonic Stem Cells.Investigating the utility of human melanoma cell lines as tumour models.Nitric oxide signaling in human ovarian cancer: A potential therapeutic target.Brief Report: Common Genetic Variation in Chromosome 10 q22.1 Shows a Strong Sex Bias in Human Embryonic Stem Cell Lines and Directly Controls the Novel Alternative Splicing of Human NODAL which is Associated with XIST Expression in Female Cell LineRUNX3 contributes to carboplatin resistance in epithelial ovarian cancer cells.CCN2 Expression by Tumor Stroma Is Required for Melanoma Metastasis.A pan-cancer analysis of secreted Frizzled-related proteins: re-examining their proposed tumour suppressive function.Nodal signals via β-arrestins and RalGTPases to regulate trophoblast invasion.Defining the Na(+)/H(+) exchanger NHE1 interactome in triple-negative breast cancer cells.Matricellular proteins in cancer: a focus on secreted Frizzled-related proteins.Beta-arrestin/Ral signaling regulates lysophosphatidic acid-mediated migration and invasion of human breast tumor cells.Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness.Focal adhesion kinase promotes the aggressive melanoma phenotype.Does nitric oxide play a role in the aetiology of pre-eclampsia?Apoptosis Induced via Gamma Delta T Cell Antigen Receptor "Blocking" Antibodies: A Cautionary TaleA Critical Review on the Effect of Docosahexaenoic Acid (DHA) on Cancer Cell Cycle Progression.Polymerase Epsilon Exonuclease Domain Mutations in Ovarian Endometrioid Carcinoma.Calpain is required for MMP-2 and u-PA expression in SV40 large T-antigen-immortalized cells.Nitric oxide-mediated regulation of hypoxia-induced B16F10 melanoma metastasis.
P50
Q24306210-0DA112D0-A31D-4376-A120-BA14239379AEQ24316417-47253738-F665-406F-830F-7A6190C13F65Q33872622-FBCEA8C5-FBE1-4D82-A3F1-CF4BC19AEDA7Q33949775-1635C3E9-CC0E-4B9D-9948-72BD7AE5959EQ33955127-DEA87422-9BFC-4134-9205-10B324E1865EQ34021289-FEEB17DA-E80B-40A4-98ED-30241BCE92E7Q34081958-1E9612AF-2F13-486E-91FF-8242DC5D890DQ34122203-771450F6-1E0E-4F2F-BA15-45E62DB30AB1Q34610503-7D6836DC-E92B-4301-B9F4-72D429C3BBF1Q35612266-CBC7E787-F992-4D6C-848F-F00FA08DD089Q35986078-B097E7A0-68C5-466D-BC85-57A7DE38C24FQ35992646-0AF5EA47-4BD1-4EA5-984D-5F336A646901Q36029979-087FAD8A-EC2C-47A2-96C2-B9A00E58A389Q36380822-EF20BB5F-23BB-4E8E-B87A-2EB8EAFDC727Q36398266-8C27BDCF-96B4-4465-97E0-B1A651495C27Q36455739-696C31BE-0108-4BC8-8EFC-6451C94EFBF5Q36567136-6111B1B5-0728-4768-9D61-00E50369D637Q36687326-8BD3F3AA-DA27-4BEF-B962-4C200B06F399Q36998375-21BB5676-4E47-430D-9496-F7AB16C10E51Q37061906-8EEF630B-B598-4F53-90CA-D09A488ABE0EQ38071851-89FEB44C-03EF-420D-BA9A-B2350F87F795Q38300154-1322643E-9002-4ED6-A701-820A0C64F330Q38722664-90ABF1BC-EE2E-4019-9923-A6A5B54097AAQ38739586-E657534B-D62D-4DD1-88E8-5E0D8A8BA4FBQ38812085-2640A4DB-856F-4725-9F57-5A780F50A86DQ38851800-73BA700F-573E-4C93-BECE-BC3ADB341C6BQ38853759-B21528FD-7365-45EC-BD0F-11E6D3E7F028Q38952038-77105C50-6123-4FA4-87DF-A8599C37FA2EQ38991266-4320A5CB-0E85-48B3-BE50-2C1F93CC84D0Q39280169-D813E403-BCE3-4D39-ACBC-411398891AB2Q39356113-D60C1E29-D3FC-4531-8C0C-B31077BBA978Q39824464-124AB0F2-BFF6-42D2-881E-058AA272E8B5Q40246647-7D291478-E59F-45B1-987A-E5398EF87292Q40355320-09AF5BD9-0EEC-42BE-8677-C27133C87D5FQ40811453-8FA369F3-56E7-465A-94ED-129289B590CCQ40989863-3828EA27-2192-4F76-BB6A-3B427C03E930Q41574351-53D50E8E-325C-4E94-91FA-3F722E794E1AQ41593170-96B7C85D-B535-4102-94A4-518244306A38Q44140863-C92736C9-4AEB-40B9-8527-F1553F9E2B52Q44656371-035058FA-33D2-4F90-9E71-D5D251980BB9
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lynne-Marie Postovit
@ast
Lynne-Marie Postovit
@en
Lynne-Marie Postovit
@es
Lynne-Marie Postovit
@nl
type
label
Lynne-Marie Postovit
@ast
Lynne-Marie Postovit
@en
Lynne-Marie Postovit
@es
Lynne-Marie Postovit
@nl
prefLabel
Lynne-Marie Postovit
@ast
Lynne-Marie Postovit
@en
Lynne-Marie Postovit
@es
Lynne-Marie Postovit
@nl
P106
P1153
8842002300
P31
P496
0000-0002-8088-4197